Xiangxue Pharmaceutical: Announcement regarding the transfer of subsidiary equity and related trade.
Xiangxue Pharmaceutical: Notice on the judicial freezing of shares held by shareholders holding 5% or more of the shares
Xiangxue Pharmaceutical: Notice on the Judicial Freezing of Some Shares Held by Shareholders Holding 5% or More
Xiangxue Pharmaceutical: Notice on the Premature Termination of the Shareholding Reduction Plan by the Controlling Shareholder
Xiangxue Pharmaceutical: Written Audit Opinions of the Board of Supervisors on the Company\'s Issuance of Shares to Specific Targets
Xiangxue Pharmaceutical: Empirical Analysis Report on the 2023 Stock Issuance Plan to Specific Targets
Xiangxue Pharmaceutical: An indicative announcement on plans to issue shares to specific targets
Xiangxue Pharmaceutical: Plans to issue shares to specific targets in 2023
Xiangxue Pharmaceutical: Announcement on Issuing Shares to Specific Targets to Dilute Spot Returns and Fulfill Return Measures and Relevant Entity Commitments
Xiangxue Pharmaceutical: Shareholder dividend return plan for the next three years (2023-2025)
Xiangxue Pharmaceutical: Announcement on Transfer of Shares and Related Transactions of Participating Companies
Xiangxue Pharmaceutical: Pre-disclosure announcement on the expiration of the share reduction period for some directors, supervisors and senior management and subsequent reduction in their holdings
Xiangxue Pharmaceutical: Pre-disclosure Notice Concerning the Expiry of the Controlling Shareholder\'s Share Reduction Plan Period and Subsequent Stock Reduction
Xiangxue Pharmaceutical: Announcement on the reduction of shareholding by some directors, supervisors and senior management by more than half of the time
Xiangxue Pharmaceutical: Announcement on shareholders holding 5% or more of the shares planned to reduce their shareholding by half
Xiangxue Pharmaceutical: Announcement on the controlling shareholder's shareholding reduction to 1%
Xiangxue Pharmaceutical: Legal opinion on the repurchase and cancellation of all restricted stocks during the third cancellation period of the 2019 Restricted Stock Incentive Plan
Xiangxue Pharmaceutical: Announcement on the repurchase and cancellation of all restricted stocks during the third cancellation period of the 2019 Restricted Stock Incentive Plan
Xiangxue Pharmaceutical: Announcement on Transfer of Shares in Subsidiaries
Xiangxue Pharmaceutical: Pre-disclosure announcement on the reduction of shares held by the controlling shareholder
No Data
No Data